Zai Lab Announces Participation in May and June Investor Conferences

Rhea-AI Summary

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) announced its senior management team participation in three key investor conferences in May and June 2024. The events include the J.P. Morgan 20th Annual Global China Summit on May 23 in Shanghai, the Jefferies Global Healthcare Conference on June 5 in New York, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 12 in Miami Beach. These conferences offer Zai Lab an opportunity to discuss its strategies, recent developments, and future plans with global investors.

Positive

• Participation in high-profile investor conferences increases company visibility.
• Opportunity to discuss strategy and developments with global investors.
• Engagement at multiple renowned events can boost investor confidence.

Negative

• No direct financial data or clinical results provided.
• High frequency of events may increase operational costs.
• Possible investor skepticism if not backed by substantial new information.

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024:

J.P. Morgan 20th Annual Global China Summit
Panel Discussion: Thursday, May 23, 2024, 10:00 a.m. HKT
Location: Shanghai, China

Jefferies Global Healthcare Conference
Fireside Chat: Wednesday, June 5, 2024, 3:30 p.m. ET in Track 2
Location: New York, New York

Goldman Sachs 45th Annual Global Healthcare Conference
Presentation: Wednesday, June 12, 2024, 1:20 p.m. ET
Location: Miami Beach, Florida

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240516389098/en/

Investor Relations:

Christine Chiou / Lina Zhang

+1 (917) 886-6929 / +86 136 8257 6943

christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com

Media:

Shaun Maccoun / Xiaoyu Chen

+1 (415) 317-7255 / +86 185 0015 5011

shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com

Source: Zai Lab Limited

FAQ

What investor conferences will Zai Lab participate in May and June 2024?

Zai Lab will participate in the J.P. Morgan 20th Annual Global China Summit on May 23, the Jefferies Global Healthcare Conference on June 5, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 12.

When and where is Zai Lab's panel discussion at the J.P. Morgan Global China Summit?

The panel discussion is on May 23, 2024, at 10:00 a.m. HKT in Shanghai, China.

What is the date and time for Zai Lab's fireside chat at the Jefferies Global Healthcare Conference?

The fireside chat is on June 5, 2024, at 3:30 p.m. ET in New York.

When will Zai Lab present at the Goldman Sachs Global Healthcare Conference?

The presentation is scheduled for June 12, 2024, at 1:20 p.m. ET in Miami Beach, Florida.

What is the significance of Zai Lab's participation in these conferences?

These conferences provide Zai Lab a platform to share its strategic vision, recent achievements, and future plans with a global audience of investors, potentially boosting investor confidence and company visibility.